Joseph J. Wolk - 12 Feb 2024 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Exec VP, CFO
Signature
/s/ Raavi K. Deol, as attorney-in-fact for Joseph J. Wolk
Issuer symbol
JNJ
Transactions as of
12 Feb 2024
Net transactions value
-$1,702,438
Form type
4
Filing time
14 Feb 2024, 18:36:45 UTC
Previous filing
12 Feb 2024
Next filing
15 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +22,119 +42% $0.000000 74,983 12 Feb 2024 Direct F1
transaction JNJ Common Stock Options Exercise $0 +3,716 +5% $0.000000 78,699 12 Feb 2024 Direct F2
transaction JNJ Common Stock Tax liability $1,702,438 -10,816 -14% $157.40 67,883 12 Feb 2024 Direct F3
holding JNJ Common Stock 2,048 12 Feb 2024 By 401k F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Performance Share Units Options Exercise $0 -22,119 -100% $0.000000* 0 12 Feb 2024 Common Stock 22,119 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024.
F2 Shares earned due to performance factor of 116.8% upon certification of performance results by the Board.
F3 Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.
F4 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).